- Home
- Companies
- micronesia
- pulmonary disease
Show results for
Refine by
Pulmonary Disease Suppliers Serving Micronesia
36 companies found
based inSan Mateo de Gállego Zaragoza, SPAIN
CerTest Biotec, S.L. is an independent biotechnology company devoted to the development and manufacturing of IVD diagnostic products in human clinical field. An innovative technology-based company whose success lies in its human capital, highly ...
CerTest Legionella one step card test is a coloured chromatographic immunoassay for the qualitative detection of Legionella pneumophila serogroup 1 in human urine samples. CerTest Legionella card test offers a highly sensitive and simple screening ...
based inTel-Aviv, ISRAEL
RedHill Biopharma (NASDAQ: RDHL) is driven to develop extraordinary medicines for people to live extraordinary lives. RedHill applies innovation, focus and a collective mindset of delivering on our promises, to build a company at the forefront of ...
RHB-204 is a proprietary, fixed-dose oral capsule containing a combination of clarithromycin, rifabutin, and clofazimine, developed for the treatment of pulmonary NTM disease caused by Mycobacterium avium Complex ...
based inFranklin, NEW JERSEY (USA)
Healthmote offers an intuitive, integrated platform that enables healthcare providers to access key Medicare programs such as Telemedicine Solutions, Video Visits, Remote Patient Monitoring (RPM), and Chronic Care Management (CCM). Focused on ...
Healthmote Remote Pulse Oximeter integrates with a state-of-the-art oximeter that offers accurate readings of blood oxygen levels, pulse rate, and perfusion index. This is particularly crucial for patients dealing with Chronic Obstructive ...
based inWixom, MICHIGAN (USA)
HumHealth Chronic Care Management solution helps practices provide non-face-to-face care to the patients with chronic conditions. Physicians can provide care management by phone or by other means and capture the time spent on managing care for ...
What is Remote Therapeutic Monitoring? Remote Therapeutic Monitoring (RTM) manages patients using devices that collect non-physiological data also called as therapeutic data. As per CMS guidelines, therapeutic data include pain levels, medication ...
based inWaltham, MASSACHUSETTS (USA)
Third Pole Therapeutics develops and delivers critical life-sustaining cardio-pulmonary therapies. Warren Zapol, M.D., Third Pole’s founder, invented the first use for inhaled nitric oxide (iNO) for the treatment of hypoxic respiratory failure in ...
based inChuncheon-si, SOUTH KOREA
JNBIO aims to make respiratory diseases measurable and more treatable. We provide cutting edge technology to enable the right decisions for patients, physicians and researchers around the ...
SPIRO LENIS Spirometer make it a useful, cost-effective device for detecting and managing pulmonary disease. It is packed with a host of features including full color touch screen, icon driven menu and highly ...
based inSydney, AUSTRALIA
Uscom Limited (UCM) is an Australian founded, ASX listed innovative medical technology company specialising in development and global marketing of premium non-invasive cardiovascular and pulmonary medical devices. Uscom has a mission to demonstrate ...
The SpiroSonic Ultrasonic spirometer employs advanced multi-path ultrasound technology to deliver high-fidelity pulmonary function ...
based inVienna, AUSTRIA
Aposcience AG is a worldwide innovation leader in the field of regenerative medicine. Regenerative medicine has the potential to transform the treatment for diseases with high medical need, as the tissues afflicted by the disease process can be ...
based inThurleigh (Bedfordshire), UNITED KINGDOM
Global Access Diagnostics (GADx) is a leading developer of lateral flow and rapid diagnostic technologies, products and services, offering a full suite of services from concept to validation to manufacturing at flexible volumes. Bringing skills ...
Chronic respiratory diseases affect nearly 550 million people worldwide. Although these conditions are incurable, treatment is available to manage symptoms. Rapid diagnostic tests are crucial in the early detection of an exacerbation, thereby ...
based inSaint Louis, MISSOURI (USA)
Sequoia Vaccines is a clinical stage pharmaceutical company discovering and developing new vaccines preventing bacterial infections and medicines treating cancers and bacterial infections. Sequoia’s lead clinical candidate is a vaccine for the ...
Sequoia is developing an anticancer compound (SQ1274) for use against solid tumors including ovarian and lung ...
based inSyracuse, NEW YORK (USA)
Mesothelioma is an aggressive cancer that affects the lining of the lungs, heart, or abdomen. Caused by the inhalation of asbestos fibers, mesothelioma is often diagnosed in older individuals who worked with asbestos products. Prognosis for ...
based inSeillans, FRANCE
RespInnovation SAS designs, develops and markets the RespIn 11 Bronchial Clearance System. A focused pulse bronchial clearance system based on high frequency chest wall oscillation (HFCWO) therapy for the treatment of many diseases with chronic ...
The newest advancement in Bronchial Clearance therapy – the RespIn Pad. Unique and exceptionally easy to use, the RespIn Pad delivers 'focused pulsations' to the patient in super comfortable and highly effective manner – literally pick ...
based inShirley, MASSACHUSETTS (USA)
In 2022, we became part of Absolute Biotech, a new company that unites multiple life science brands into one organization specializing in antibody reagents and services. Learn more at absolutebiotech.com. The extensive LSBio reagent catalog contains ...
LTB4R2 is a low-affinity receptor for leukotrienes including leukotriene B4. It mediates the chemotaxis of granulocytes and macrophages. The response is mediated via G-proteins that activate a phosphatidylinositol-calcium second messenger system. ...
based inTotowa, NEW JERSEY (USA)
VectraCor uses its patented technology to design and develop medical devices to simplify and reduce costs of diagnostic testing as well as improve patient care. Our latest technology, VectraplexECG can detect ECG changes suggestive of a heart attack ...
based inIrvine, CALIFORNIA (USA)
Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring. Driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart ...
The first transcatheter heart valve approved for pre-stented transannular patches. Also approved for use in the pulmonic position in conduits and ...
based inPlan-les-Ouates, SWITZERLAND
Adiposs is a biotech start-up company, a spin-off from the University of Geneva. The company is incorporated in the Canton of Geneva, Switzerland. Adiposs is developing first-in-class medical imaging products and technologies. Adiposs has developed ...
Adiposs has developed ImageBAT, the first product that makes brown and beige adipose tissue (BAT) visible with a fast and pain-free CT scan. It enables early detection of body wasting before patients lose body weight. The diagnostic procedure with ...
based inDos Hermanas (Sevilla), SPAIN
Vaxdyn was founded in 2011 as a spin-off established by researchers of the Institute of Biomedicine of Seville, a center of the Andalusian Public Health System and the University of Seville linked to the University Hospital Virgen del Rocío of ...
based inRostock, GERMANY
The founding of TUR group is an important milestone in our quest toward the establishment of the complete customer support service stipulated in our corporate philosophy. Trends, customer needs and markets are constantly changing. To be successful ...
Severe hypoxia is well known to be associated with deleterious consequences for the human body. For example, obstructive sleep apnea with brief and frequently recurrent cycles of hypoxia has been found to be linked to hypertension, stroke, and ...
based inCalgary, ALBERTA (CANADA)
Circle improves patient outcome by revolutionizing the cardiovascular healthcare industry through innovation, and enabling healthcare providers to complete effective and precise analysis. The Global Leader in Cardiac Imaging Solutions. Physicians ...
cvi42 for Cardiac MRI has the most clinically cleared tools for diagnosis, and the most accurate tools to quantify and qualify for research purposes. ...
based inSilver Spring, MARYLAND (USA)
We are the first publicly-traded biotech or pharmaceutical company to take the form of a public benefit corporation (PBC). Our public benefit purpose is to provide a brighter future for patients through (a) the development of novel pharmaceutical ...
Adcirca is a phosphodiesterase 5 (PDE-5) inhibitor indicated for the treatment of pulmonary arterial hypertension (PAH)(WHO Group 1) to improve exercise ability. Studies establishing effectiveness included predominately patients ...